How the FDA Buried the Dangers of…

In the first part of this series (which must be read before this part), I argued that SSRI antidepressants provide minimal benefit (around 20% of recipients experience a benefit) and frequently cause significant harm. On that basis, it is highly problematic they were ever FDA approved, particularly since they are given out like candy and over 10% of the American population is on them. However, while there are many “bad” drugs on the market, SSRIs (and to a lesser extent a few other psychiatric medications) have a unique side effect that…as much as I am reluctant to use this terminology…can only be described as demonic.

Read →